ArticleRwanda journal of medicine and health sciences2026
Clinical Significance of Lipoprotein and Ceruloplasmin Variations in Type 2 Diabetes Mellitus: A Cross-Sectional Study in Owo, Nigeria.
Article in Rwanda journal of medicine and health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance leading to hyperglycemia, dyslipidemia, and oxidative stress. Ceruloplasmin (CP), the major oxidase and copper-binding protein, has recently been under investigation as an indicator of metabolic dysfunction. Increased CP levels cause oxidative stress and inflammation and thus promote numerous cardiovascular and renal complications. Determination of CP could serve as an early reliable biomarker for timely intervention in the holistic management of T2DM. The present study was designed to compare lipoprotein levels, CP, and oxidative stress markers between participants with diabetes and those without diabetes. Methods: Fifty patients with T2DM were evaluated along with 30 age- and sex-matched non-diabetic controls visiting Federal Medical Centre, Owo. Standard enzymatic and ELISA techniques assessed biochemical parameters such as fasting blood sugar (FBS), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), CP, malondialdehyde (MDA), and total antioxidant status (TAS). Data were analyzed by SPSS Version 25. The independent t-test was then used to determine the difference between group means in the biochemical markers. Spearman's correlation was applied to establish relationships, and the level of significance was set at p<0.05. Results: The FBS, CP, TC, TG, HDL, VLDL, and MDA levels were all statistically significant in patients with T2DM, while TAS decreased remarkably (p<0.05). Obese participants showed exacerbated dyslipidemia and oxidative stress. Positive correlations were observed between CP and lipid parameters, while MDA negatively correlated with TAS. Conclusion: Ceruloplasmin was raised in T2DM, dyslipidemia, and lowered antioxidant capability were early markers that prompt intervention for oxidative stress and biochemical derangements in patients with T2DM. In this regard, CP could potentially emerge as a novel marker to monitor the progression of complications in T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.